Estrogens, Conjugated (USP)

"Estrogens, Conjugated (USP)" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.

Descriptor ID	D004966
MeSH Number(s)	D06.472.334.851.437.988
Concept/Terms	Estrogens, Conjugated (USP) Estrogens, Conjugated (USP) Estrogens, Conjugated Estrogenic Hormones, Conjugated Conjugated Estrogenic Hormones Conjugated Estrogens Estrogenic Substances, Conjugated Conjugated Estrogenic Substances Congest Congest Conjugated Equine Estrogens Conjugated Equine Estrogens Equine Estrogens, Conjugated Dagynil Dagynil Oestrofeminal Oestrofeminal Oestro-Feminal Oestro Feminal Estro-Feminal Estro Feminal Premarin Premarin Climopax Climarest Presomen Presomen Progens Progens Transannon Transannon Femavit Carentil Carentil Prelestrin Prelestrin

Below are MeSH descriptors whose meaning is more general than "Estrogens, Conjugated (USP)".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormones [D06.472]
Gonadal Hormones [D06.472.334]
Gonadal Steroid Hormones [D06.472.334.851]
Estradiol Congeners [D06.472.334.851.437]
Estrogens, Conjugated (USP) [D06.472.334.851.437.988]

Below are MeSH descriptors whose meaning is related to "Estrogens, Conjugated (USP)".

Below are MeSH descriptors whose meaning is more specific than "Estrogens, Conjugated (USP)".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Estrogens, Conjugated (USP)" by people in this website by year, and whether "Estrogens, Conjugated (USP)" was a major or minor topic of these publications.

Bar chart showing 17 publications over 10 distinct years, with a maximum of 4 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	1	0	1
2003	1	1	2
2005	0	1	1
2006	1	0	1
2008	2	0	2
2009	2	0	2
2010	2	0	2
2011	1	0	1
2014	1	0	1
2015	3	1	4

Below are the most recent publications written about "Estrogens, Conjugated (USP)" by people in Profiles.

Han SJ, Begum K, Foulds CE, Hamilton RA, Bailey S, Malovannaya A, Chan D, Qin J, O'Malley BW. The Dual Estrogen Receptor a Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety. Mol Pharmacol. 2016 Jan; 89(1):14-26.

View in: PubMed
Shea KL, Gavin KM, Melanson EL, Gibbons E, Stavros A, Wolfe P, Kittelson JM, Vondracek SF, Schwartz RS, Wierman ME, Kohrt WM. Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment. Menopause. 2015 Oct; 22(10):1045-52.

View in: PubMed
Jordan VC, Maximov PY, Fan P. Progesterone and Synthetic Progestin Controversies. JAMA Oncol. 2015 Oct; 1(7):986-7.

View in: PubMed
Espeland MA, Brinton RD, Manson JE, Yaffe K, Hugenschmidt C, Vaughan L, Craft S, Edwards BJ, Casanova R, Masaki K, Resnick SM. Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. Neurology. 2015 Sep 29; 85(13):1131-8.

View in: PubMed
Swanick CW, Castle KO, Rechner LA, Rauch GM, Jhingran A, Eifel PJ, Klopp AH. Optimizing packing contrast for MRI-based intracavitary brachytherapy planning for cervical cancer. Brachytherapy. 2015 May-Jun; 14(3):385-9.

View in: PubMed
Smith CL, Santen RJ, Komm B, Mirkin S. Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes. Breast Cancer Res. 2014 Jun 18; 16(3):212.

View in: PubMed
Tang JY, Spaunhurst KM, Chlebowski RT, Wactawski-Wende J, Keiser E, Thomas F, Anderson ML, Zeitouni NC, Larson JC, Stefanick ML. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials. J Natl Cancer Inst. 2011 Oct 05; 103(19):1469-75.

View in: PubMed
LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA. 2011 Apr 06; 305(13):1305-14.

View in: PubMed
Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, Rajkovic A, Rohan TE, Yasmeen S, Prentice RL. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA. 2010 Oct 20; 304(15):1684-92.

View in: PubMed
Edlefsen KL, Jackson RD, Prentice RL, Janssen I, Rajkovic A, O'Sullivan MJ, Anderson G. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women. Menopause. 2010 May-Jun; 17(3):622-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals